Levetiracetam price December 2025 and outlook (see chart below)
- India:US$35.56/KG, 0.3% up
Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.
NEED A QUICK DOWNLOAD?
ACCESS TO OUR FULL DATABASE IS US$399/YEAR, WITH A 30-DAY $50 TRIAL
GET THAT DOWNLOAD IN 3 MINUTES!
BusinessAnalytiq provides a database of hundreds of market & price trend data, as well as online tools to set up benchmarks and leading indicators.
Levetiracetam price index
This post is a summary of the Levetiracetam price developments. The price developments of Levetiracetam are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Levetiracetam price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.
The outlook for Levetiracetam prices is generated from different inputs including:
- Very recent price developments of immediate cost drivers of Levetiracetam prices
- Recent price developments of underlying feedstocks which drive the price of Levetiracetam
- Market futures for both cost drives and feedstocks of Levetiracetam prices
- Adjustment of current supply/demand imbalances in the Levetiracetam market
- Longer term trends in likely demand conditions
What is Levetiracetam and What is it Used For
Levetiracetam is an anticonvulsant medication used to treat epilepsy. It helps control seizures by stabilizing electrical activity in the brain. It is commonly prescribed for partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures in adults and children.
How is Levetiracetam
Levetiracetam is available in tablet, oral solution, and injectable forms. It is usually taken twice daily, with or without food, and dosage is adjusted based on age, weight, and kidney function. The medication is generally well-tolerated, with common side effects including drowsiness, dizziness, and fatigue.
How Large is the Global Market for Levetiracetam
The global market for Levetiracetam is significant, valued at several billion USD annually. Growth is driven by increasing prevalence of epilepsy, rising awareness, and wider availability of generic versions. North America and Europe are key markets, with expanding demand in Asia-Pacific regions.
Where is Levetiracetam Produced
Levetiracetam is manufactured by several pharmaceutical companies worldwide, including major producers in the United States, Europe, and India. Both brand-name and generic versions are produced, with India serving as a key supplier of cost-effective generics for global markets.